Provided are: a nucleic acid molecule capable of binding to c-Met, which is a substance that can be used for analysis of the mechanism of development, diagnosis and treatment of diseases that are induced by c-Met； and use of the nucleic acid molecule capable of binding to c-Met. This nucleic acid molecule capable of binding to c-Met is any one of the following nucleic acid molecules (A1), (A2), (B1) and (B2). (A1) a nucleic acid molecule which comprises one of the nucleotide sequences represented by SEQ ID NOS: 1-38 (A2) a nucleic acid molecule which comprises a nucleotide sequence that is produced by substituting, deleting, adding or inserting one or more nucleotides in one of the nucleotide sequences represented by SEQ ID NOS: 1-38 and which is capable of binding to c-Met (B1) a nucleic acid molecule which comprises one of the nucleotide sequences represented by SEQ ID NOS: 39-76 (B2) a nucleic acid molecule which comprises a nucleotide sequence that is produced by substituting, deleting, adding or inserting one or more nucleotides in one of the nucleotide sequences represented by SEQ ID NOS: 39-76 and which is capable of binding to c-Met
